ELACLOX DCX DRY COW INTRAMAMMARY SUSPENSION

Land: Australien

Sprog: engelsk

Kilde: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Køb det nu

Indlægsseddel Indlægsseddel (PIL)
20-06-2017
Produktets egenskaber Produktets egenskaber (SPC)
20-06-2017

Aktiv bestanddel:

CLOXACILLIN AS THE BENZATHINE SALT

Tilgængelig fra:

NORBROOK LABORATORIES AUSTRALIA PTY LIMITED

INN (International Name):

cloxacillin as benzathine(600mg/Sg)

Lægemiddelform:

MISC. INTRA MAMMARY

Sammensætning:

CLOXACILLIN AS THE BENZATHINE SALT ANTIBIOTIC Active 600.0 mg/5.4gS

Enheder i pakken:

20 Syrs; 200 Syrs

Klasse:

VM - Veterinary Medicine

Terapeutisk gruppe:

DAIRY CATTLE | BOVINE | BREEDERS | CALVES | DAIRY COW | GROWERS | LACTATING COW | MILKING COW

Terapeutisk område:

ANTIBIOTIC & RELATED

Terapeutiske indikationer:

MASTITIS | SUBCLINICAL MASTITIS

Produkt oversigt:

Poison schedule: 4; Withholding period: WHP: Milk: Do not use in lactating cows due to calve within 35 days after tre atment. Milk from treated cows must not be used for human consumption or suppl ied for processing for 96 hours (8 milk ings) after calving. Meat: Do not use l ess than 30 days before slaughter for h uman consumption. ESI: Does not have ES I; Host/pest details: DAIRY CATTLE: [MASTITIS]; Poison schedule: 4; Withholding period: ; Host/pest details: DAIRY CATTLE: [MASTITIS]; For control of mastitis in dairy cows caused by Streptococcus spp., Staphylococcus spp. (including penicillin resistant strains), Arcanobacterium spp. and other organisms susceptible to cloxacillin.Do not use in lactating cows due to calve within 35 days of treatment. Do not use in cows allergic to penicillin

Autorisation status:

Registered

Autorisation dato:

2023-07-01

Indlægsseddel

                                Info
PEST

Verified
                                
                                Læs hele dokumentet
                                
                            

Produktets egenskaber

                                PRODUCT NAME: ELACLOX DCX DRY COW INTRAMAMMARY SUSPENSION
PAGE: 1 OF 4
THIS REVISION ISSUED: SEPTEMBER, 2009
MATERIAL SAFETY DATA SHEET
Issued by: Norbrook Laboratories Australia Pty Ltd
Freecall: 1800 665 866
POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800
764 766 IN NEW ZEALAND)
SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY
NORBROOK LABORATORIES AUSTRALIA PTY LTD
FREECALL: 1800 665 866
UNIT 7/1 TRADE PARK DRIVE
TULLAMARINE, VIC 3043 AUSTRALIA
SUBSTANCE:
Penicillin derivatives.
TRADE NAME:
ELACLOX DCX DRY COW INTRAMAMMARY SUSPENSION
APVMA CODE:
51848
PRODUCT USE:
An intramammary suspension containing cloxacillin (as the benzathine
salt) in a long
acting base with aluminium stearate for the control of mastitis in
dairy cows.
CREATION DATE:
SEPTEMBER, 2009
THIS VERSION ISSUED:
SEPTEMBER, 2009
and is valid for 5 years from this date.
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as:
Not classified as hazardous according to the criteria of SWA.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
S36, S24/25. Wear suitable protective clothing. Avoid contact with
skin and eyes.
SUSDP CLASSIFICATION:
S4
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
EMERGENCY OVERVIEW
PHYSICAL DESCRIPTION & COLOUR
: Off-white to creamy liquid suspension.
ODOUR:
Virtually odourless.
MAJOR HEALTH HAZARDS:
This is an antibiotic preparation. Any person with a history of
allergies to this class of
substances should avoid all contact with this product as it may cause
sensitisation. This is a physiologically active
product and so contact should be minimised, especially if the user is
taking a form of medication, as interactions can
sometimes give unexpected and undesired results.
POTENTIAL HEALTH EFFECTS
INHALATION:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. In addition
product is un
                                
                                Læs hele dokumentet